Literature DB >> 18779288

Low plasma eicosapentaenoic acid and depressive symptomatology are independent predictors of dementia risk.

Cécilia Samieri1, Catherine Féart, Luc Letenneur, Jean-François Dartigues, Karine Pérès, Sophie Auriacombe, Evelyne Peuchant, Cécile Delcourt, Pascale Barberger-Gateau.   

Abstract

BACKGROUND: The potential preventive role of polyunsaturated fatty acids (PUFAs) in Alzheimer disease has aroused increasing interest. Plasma n-3 PUFAs have been shown to be inversely related to the risk of dementia and to depression, which is frequently associated with dementia.
OBJECTIVE: The objective was to ascertain whether plasma PUFAs predict the risk of incident dementia in a cohort of older persons, independently of their depressive status.
DESIGN: Of 1214 nondemented participants in the Three-City Study from Bordeaux (France) who were followed up for 4 y, 65 developed dementia. The association between the proportion of plasma fatty acids at baseline and the risk of incident dementia was assessed by multivariate proportional hazard models, taking into account depressive status assessed on the basis of the Center for Epidemiologic Studies Depression scale.
RESULTS: A higher plasma eicosapentaenoic acid (EPA) concentration was associated with a lower incidence of dementia [hazard ratio (HR) for 1 SD = 0.69; 95% CI: 0.48, 0.98], independently of depressive status and after adjustment for age, education, apolipoprotein E epsilon4 allele, diabetes, and baseline plasma vitamin E and triacylglycerol. The relations between docosahexaenoic acid (DHA), total n-3 PUFAs, and incident dementia did not remain significant in multivariate models. Higher ratios of arachidonic acid (AA) to DHA and of n-6 to n-3 fatty acids were related to an increased risk of dementia, particularly in depressive subjects (n = 90): ratio of AA to DHA (HR: 2.65; 95% CI: 1.07, 6.56) and ratio of n-6 to n-3 (HR: 1.61; 95% CI: 1.04, 2.47).
CONCLUSIONS: A high plasma EPA concentration may decrease the risk of dementia, whereas high ratios of n-6 to n-3 fatty acids and of AA to DHA may increase the risk of dementia, especially in depressed older persons. The role of EPA in dementia warrants further research.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18779288     DOI: 10.1093/ajcn/88.3.714

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  51 in total

1.  Combination of EPA with Carotenoids and Polyphenol Synergistically Attenuated the Transformation of Microglia to M1 Phenotype Via Inhibition of NF-κB.

Authors:  Nurit Hadad; Rachel Levy
Journal:  Neuromolecular Med       Date:  2017-08-04       Impact factor: 3.843

2.  Effect of dietary interventions in mild cognitive impairment: a systematic review.

Authors:  Andrea M McGrattan; Claire T McEvoy; Bernadette McGuinness; Michelle C McKinley; Jayne V Woodside
Journal:  Br J Nutr       Date:  2018-11-09       Impact factor: 3.718

3.  High dietary and plasma levels of the omega-3 fatty acid docosahexaenoic acid are associated with decreased dementia risk: the Rancho Bernardo study.

Authors:  L B Lopez; Donna Kritz-Silverstein; Elizabeth Barrett Connor
Journal:  J Nutr Health Aging       Date:  2011-01       Impact factor: 4.075

Review 4.  Dietary omega 3 polyunsaturated fatty acids and Alzheimer's disease: interaction with apolipoprotein E genotype.

Authors:  P Barberger-Gateau; C Samieri; C Féart; M Plourde
Journal:  Curr Alzheimer Res       Date:  2011-08       Impact factor: 3.498

5.  Omega-3 fatty acid supplementation decreases DNA damage in brain of rats subjected to a chemically induced chronic model of Tyrosinemia type II.

Authors:  Milena Carvalho-Silva; Lara M Gomes; Giselli Scaini; Joyce Rebelo; Adriani P Damiani; Maiara Pereira; Vanessa M Andrade; Fernanda F Gava; Samira S Valvassori; Patricia F Schuck; Gustavo C Ferreira; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2017-03-18       Impact factor: 3.584

6.  Relationship between diet and plasma long-chain n-3 PUFAs in older people: impact of apolipoprotein E genotype.

Authors:  Cécilia Samieri; Simon Lorrain; Benjamin Buaud; Carole Vaysse; Claudine Berr; Evelyne Peuchant; Stephen C Cunnane; Pascale Barberger-Gateau
Journal:  J Lipid Res       Date:  2013-06-25       Impact factor: 5.922

7.  Omega-3 fatty acids and mood stabilizers alter behavioral and oxidative stress parameters in animals subjected to fenproporex administration.

Authors:  Lara M Gomes; Milena Carvalho-Silva; Letícia J Teixeira; Joyce Rebelo; Isabella T Mota; Rafaela Bilesimo; Monique Michels; Camila O Arent; Edemilson Mariot; Felipe Dal-Pizzol; Giselli Scaini; João Quevedo; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2016-12-16       Impact factor: 3.584

Review 8.  Nutrition and brain aging: how can we move ahead?

Authors:  P Barberger-Gateau
Journal:  Eur J Clin Nutr       Date:  2014-08-27       Impact factor: 4.016

Review 9.  An update on the role of omega-3 fatty acids on inflammatory and degenerative diseases.

Authors:  Silvia Lorente-Cebrián; André G V Costa; Santiago Navas-Carretero; María Zabala; Laura M Laiglesia; J Alfredo Martínez; María J Moreno-Aliaga
Journal:  J Physiol Biochem       Date:  2015-03-11       Impact factor: 4.158

Review 10.  Omega-3 fatty acids and cognitive function in women.

Authors:  Jennifer G Robinson; Nkechinyere Ijioma; William Harris
Journal:  Womens Health (Lond)       Date:  2010-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.